People · Operator
Named in public records as an officer, director or promoter · active 2011–2021 · Biotechnology, Other Travel
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cerium Pharmaceuticals, Inc. | — | Biotechnology | Series A | $13.1M | $193.4M | 2021 |
| Ridecharge Inc | — | Other Travel | Series A | $12.1M | $12.3M | 2011 |
Thomas A DePasquale at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas A DePasquale on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Gale | 1 | 5 |
| John A Torrey | 1 | 1 |
| Nicholas A Perrins | 1 | 1 |
| E Sanders Partee | 1 | 1 |
| Gregg Lapointe | 1 | 1 |
| Nancy Klett | 1 | 1 |
| Dean A Morehouse | 1 | 1 |
| Mark A Joseph | 1 | 1 |
| Patrick A Lashinsky | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.